In this review
Start with the person responsible for your weight care
Empower’s patient process asks you to see a preferred provider, have the prescription sent to the pharmacy and arrange delivery or Houston pickup. The FAQ says a pharmacist cannot recommend a particular doctor. That leaves the choice of clinician and ongoing support as separate decisions. Pharmacy access is useful only within a care arrangement that meets the reader’s needs. [1] [2]
I would ask who reviews symptoms and results, handles a medication change and provides nutrition support when needed. A dispensing service does not establish private dietitian sessions or a structured behavioural programme. If a clinic packages Empower medication with care, compare the clinic’s actual agreement as well; its fee, renewal and follow-up obligations may differ from the pharmacy’s. [1] [2]
Obtain two clear quotes if there are two relationships
The pharmacy says it requires the prescription to determine a price. It does not fill solely because the doctor called it in; patient approval is needed. No public fixed monthly medication-and-care amount is established. Request the medication, supplies, shipping and any repeat-order terms, then enter those charges in the cost planner alongside the separate professional fees. Keep any unquoted repeat-order costs blank. [2]
Empower says it does not accept insurance. Its shipping FAQ lists different services and higher rates for Hawaii, Alaska and Puerto Rico, with refrigerated prescriptions scheduled for overnight shipment Monday through Thursday. Those are shipping descriptions, not guaranteed total turnaround. A prescription quote from Strive Pharmacy gives you another delivered price to compare. Include any fees billed separately by your clinician. [2]
The pharmacy record is part of the buying decision
FDA issued a September 18, 2026 warning to Empower’s Houston 503A operation after a November 2025 inspection. The letter addresses certain compounded GLP-1 combinations and sterile-production deficiencies. It acknowledges some apparently adequate corrections and explains why others were deficient or could not be fully evaluated. I would want a current explanation of the findings relevant to the proposed prescription. [5]
The warning does not establish that an individual current order is contaminated, that every product was recalled or that the business closed. The 503A pharmacy and 503B office-use facility have distinct regulatory records. Quality-page claims about accreditation and testing do not independently resolve that history or verify a patient’s batch. Ask the prescriber and dispenser for the current, product-specific answer. [5] [6] [7]
Plan the refill and problem-resolution steps
The current catalogue names semaglutide/cyanocobalamin and tirzepatide/niacinamide injections. They are compounded products, not FDA-approved finished medicines; an added vitamin does not establish better weight-loss results. Confirm the actual preparation, quantity and handling instructions. A long supply should not be treated as permission to use an opened container beyond its applicable instructions. [3] [4] [8]
Empower says it does not refill automatically. Ordinary product returns are generally declined, with limited returns or credits considered after investigation; the FAQ does not establish a universal cash-refund deadline. Lost-package replacement depends on an available refill and investigation, not a clearly stated free remedy. For an injectable GLP-1 parcel arriving warm or insufficiently refrigerated, FDA advises against use. My decision would turn on suitable care, a transparent combined bill and a clear route for problems. [2] [9]
Understanding the cost
Empower requires a prescription to quote the medication. Add the prescriber’s visits, monitoring, support and actual shipping/supply charges before comparing programme costs. The pharmacy says it does not accept insurance; no insurance reimbursement or universal all-in cash rate is established. [1] [2]
Build your cost estimateSources
- Empower Pharmacy: obtaining a prescription through a separate provider
- Empower Pharmacy: expanded patient, pricing, refill, return and shipping answers
- Empower Pharmacy: semaglutide/cyanocobalamin injection
- Empower Pharmacy: tirzepatide/niacinamide injection
- FDA: September 18, 2026 Empower Pharmacy warning letter, 503A facility
- FDA: separately listed Empower 503A and 503B inspection actions
- Empower Pharmacy: quality claims and facility distinctions
- FDA: understanding the risks of compounded drugs
- FDA: concerns with unapproved GLP-1 drugs and shipment refrigeration
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.